Compound Detail
CHEMBL4642929
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4642929 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | STSWANNXUFYIKJ-NDENLUEZSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
335.4
MW (Da)
4.35
ALogP
4
HBA
0
HBD
46.6
PSA (Ų)
0.60
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.64
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| K562 | IC50 | = | 230.0 | nM | 6.64 | Cytotoxicity against human K562 cells assessed as reduction in cell viability by... | 30739824 |
| HT-29 | IC50 | = | 230.0 | nM | 6.64 | Cytotoxicity against human HT-29 cells assessed as reduction in cell viability b... | 30739824 |
| HepG2 | IC50 | = | 230.0 | nM | 6.64 | Cytotoxicity against human HepG2 cells assessed as reduction in cell viability b... | 30739824 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30739824 | 10.1016/j.ejmech.2019.01.078 | K562 | 1 |
| 30739824 | 10.1016/j.ejmech.2019.01.078 | HT-29 | 1 |
| 30739824 | 10.1016/j.ejmech.2019.01.078 | HepG2 | 1 |
Data from ChEMBL 36 via Core Engine